The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaruwa Regulatory News (MAW)

Share Price Information for Maruwa (MAW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28,000.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 28,000.00
MAW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

31 Jan 2023 07:00

RNS Number : 3812O
Maruwa Co Ld
31 January 2023
 

Translation

 

Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.

 

Summary of Consolidated Financial Results

for the Nine Months Ended December 31, 2022

(Based on Japanese GAAP)

January 31, 2023

Company name:

MARUWA CO., LTD.

Stock exchange listing:

Tokyo, Nagoya

Stock code:

5344

URL https://www.maruwa-g.com/

Representative:

President and Representative Director

Toshiro Kanbe

Inquiries:

Director

Yukiko Morishita

TEL 0561-51-0841

Scheduled date to file Quarterly Securities Report:

February 10, 2023

Scheduled date to commence dividend payments:

-

Preparation of supplementary material on quarterly financial results:

No

Holding of quarterly financial results meeting:

Yes

(for analysts and institutional investors)

 

(Amounts less than one million yen are rounded down)

1. Consolidated financial results for the nine months ended December 31, 2022 (from April 1, 2022 to December 31, 2022)

(1) Consolidated operating results (cumulative)

Percentages indicate year-on-year changes

 

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Nine months ended December 31, 2022

44,577

11.2

16,039

20.0

16,982

22.9

11,934

25.5

Nine months ended December 31, 2021

40,070

31.1

13,361

76.4

13,819

86.4

9,511

87.3

 

 

Earnings per share

Diluted earnings per share

Yen

Yen

Nine months ended December 31, 2022

967.35

-

Nine months ended December 31, 2021

770.98

-

 

(2) Consolidated financial position

Total assets

Net assets

Equity ratio

Millions of yen

Millions of yen

%

As of December 31, 2022

102,775

91,029

88.6

As of March 31, 2022

95,899

79,681

83.1

 

 

2. Cash dividends

 

Annual dividends per share

1st quarter-end

2nd quarter-end

3rd quarter-end

Fiscal year-end

Total

Yen

Yen

Yen

Yen

Yen

Year ended March 31, 2022

-

34.00

-

36.00

70.00

Year ending March 31, 2023

-

38.00

-

Year ending March 31, 2023 (Forecast)

40.00

78.00

 

3. Forecast of consolidated financial results for the year ending March 31, 2023 (from April 1, 2022 to March 31, 2023)

Percentages indicate year-on-year changes

 

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Earnings per share

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

Full year

59,100

8.8

20,800

14.2

21,000

9.5

14,700

10.1

1,191.49

 

4. Notes

(1) Changes in significant subsidiaries during the nine months ended December 31, 2022

(changes in specified subsidiaries resulting in the change in scope of consolidation):

Yes

 

(2) Application of special accounting methods for preparing quarterly consolidated financial statements:

No

 

(3) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements

Changes in accounting policies due to revisions to accounting standards and other regulations:

No

Changes in accounting policies due to other reasons:

No

Changes in accounting estimates:

No

Restatement of prior period financial statements:

No

 

(4) Number of issued shares (common shares)

Total number of issued shares at the end of the period (including treasury shares)

As of December 31, 2022

12,372,000

 shares

As of March 31, 2022

12,372,000

 shares

Number of treasury shares at the end of the period

As of December 31, 2022

34,599

 shares

As of March 31, 2022

34,492

 shares

Average number of shares during the period (cumulative from the beginning of the fiscal year)

Nine months ended December 31, 2022

12,337,418

 shares

Nine months ended December 31, 2021

12,337,311

 shares

 

 

 

 

Quarterly consolidated financial statements

Consolidated balance sheets

 

 

(Millions of yen)

 

As of March 31, 2022

As of December 31, 2022

Assets

 

 

Current assets

 

 

Cash and deposits

44,621

48,613

Notes receivable - trade

473

359

Accounts receivable - trade

12,876

11,636

Electronically recorded monetary claims - operating

1,810

1,982

Merchandise and finished goods

1,632

2,451

Work in process

2,648

2,920

Raw materials and supplies

3,706

3,982

Other

2,389

1,755

Allowance for doubtful accounts

(9)

(9)

Total current assets

70,149

73,693

Non-current assets

 

 

Property, plant and equipment

 

 

Buildings and structures, net

10,101

10,157

Machinery, equipment and vehicles, net

5,478

7,447

Land

4,699

4,838

Construction in progress

2,653

4,065

Other, net

590

701

Total property, plant and equipment

23,524

27,209

Intangible assets

 

 

Other

298

291

Total intangible assets

298

291

Investments and other assets

1,927

1,581

Total non-current assets

25,750

29,082

Total assets

95,899

102,775

 

 

 

 

 

(Millions of yen)

 

As of March 31, 2022

As of December 31, 2022

Liabilities

 

 

Current liabilities

 

 

Notes and accounts payable - trade

3,444

2,996

Electronically recorded obligations - operating

2,419

1,681

Short-term borrowings

100

100

Current portion of long-term borrowings

866

799

Income taxes payable

4,731

1,512

Provision for bonuses

866

444

Provision for bonuses for directors (and other officers)

71

64

Other

2,455

2,987

Total current liabilities

14,953

10,586

Non-current liabilities

 

 

Long-term borrowings

733

600

Deferred tax liabilities

153

196

Other

377

363

Total non-current liabilities

1,264

1,159

Total liabilities

16,218

11,746

Net assets

 

 

Shareholders' equity

 

 

Share capital

8,646

8,646

Capital surplus

12,017

12,018

Retained earnings

59,274

70,296

Treasury shares

(207)

(208)

Total shareholders' equity

79,732

90,753

Accumulated other comprehensive income

 

 

Valuation difference on available-for-sale securities

104

92

Foreign currency translation adjustment

(155)

183

Total accumulated other comprehensive income

(51)

276

Total net assets

79,681

91,029

Total liabilities and net assets

95,899

102,775

 

 

 

Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative)

Consolidated statements of income (cumulative)

 

 

(Millions of yen)

 

Nine months ended

December 31, 2021

Nine months ended

December 31, 2022

Net sales

40,070

44,577

Cost of sales

19,876

20,972

Gross profit

20,194

23,604

Selling, general and administrative expenses

6,833

7,565

Operating profit

13,361

16,039

Non-operating income

 

 

Interest income

45

62

Rental income

72

72

Foreign exchange gains

333

819

Other

55

38

Total non-operating income

507

993

Non-operating expenses

 

 

Interest expenses

6

4

Rent expenses on real estate for investments

33

33

Other

9

12

Total non-operating expenses

49

50

Ordinary profit

13,819

16,982

Extraordinary income

 

 

Gain on sale of non-current assets

3

0

Gain on liquidation of subsidiaries

-

3

Subsidy income

89

15

Total extraordinary income

92

19

Extraordinary losses

 

 

Loss on sale and retirement of non-current assets

17

32

Loss on tax purpose reduction entry of non-current assets

75

-

Loss related to infectious disease

41

-

Total extraordinary losses

133

32

Profit before income taxes

13,778

16,969

Income taxes - current

4,180

4,621

Income taxes - deferred

85

412

Total income taxes

4,266

5,034

Profit

9,511

11,934

Profit attributable to owners of parent

9,511

11,934

 

 

 

Consolidated statements of comprehensive income (cumulative)

 

 

(Millions of yen)

 

Nine months ended

December 31, 2021

Nine months ended

December 31, 2022

Profit

9,511

11,934

Other comprehensive income

 

 

Valuation difference on available-for-sale securities

(0)

(12)

Foreign currency translation adjustment

320

339

Total other comprehensive income

319

327

Comprehensive income

9,831

12,261

Comprehensive income attributable to

 

 

Comprehensive income attributable to owners of parent

9,831

12,261

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTUAONRORUAORR
12
Date   Source Headline
25th Apr 202410:29 amRNSFinal Results
31st Jan 20248:31 amRNS3rd Quarter Results
26th Oct 20238:46 amRNSHalf-year Report
27th Jul 20238:22 amRNS1st Quarter Results
27th Apr 20239:52 amRNSFinal Results
31st Jan 20237:00 amRNS3rd Quarter Results
27th Oct 202210:40 amRNSHalf-year Report
27th Jul 202210:31 amRNS1st Quarter Results
27th Apr 202210:32 amRNSFinal Results
28th Jan 20227:00 amRNS3rd Quarter Results
27th Oct 20212:08 pmRNSHalf-year Report
27th Jul 20219:24 amRNS1st Quarter Results
27th Apr 202110:15 amRNSFinal Results
28th Jan 20219:37 amRNS3rd Quarter Results
28th Oct 20209:20 amRNSHalf-year Report
27th Jul 202010:27 amRNS1st Quarter Results
28th Apr 20209:54 amRNSFinal Results
30th Jan 20209:00 amRNS3rd Quarter Results
30th Oct 20199:23 amRNSHalf-year Report
30th Jul 201910:59 amRNS1st Quarter Results
26th Apr 201910:37 amRNSFinal Results
31st Jan 201910:40 amRNS3rd Quarter Results
30th Oct 201810:22 amRNSHalf-year Report
26th Jul 201811:05 amRNS1st Quarter Results
27th Apr 20189:32 amRNSFinal Results
30th Jan 20189:39 amRNS3rd Quarter Results
31st Oct 201710:19 amRNSHalf-year Report
25th Jul 201711:16 amRNS1st Quarter Results
8th May 201711:32 amRNSFinal Results FY2016
2nd Feb 201710:11 amRNS3rd Quarter Results
31st Oct 201610:19 amRNSHalf-year Report
28th Jul 201611:59 amRNS1st Quarter Results
29th Apr 20167:28 amRNSFinal Results
4th Feb 201610:16 amRNS3rd Quarter Results
30th Oct 20157:00 amRNSHalf Yearly Report
30th Jul 201511:09 amRNS1st Quarter Results
29th Apr 20158:32 amRNSFinal Results
6th Feb 201510:31 amRNS3rd Quarter Results
30th Oct 20141:08 pmRNSHalf Yearly Report
30th Jul 20142:21 pmRNS1st Quarter Results
14th May 20147:00 amRNSFinal Results
6th Feb 201410:25 amRNS3rd Quarter Results
12th Nov 201312:32 pmRNSHalf Yearly Report
6th Aug 201312:07 pmRNS1st Quarter Results
17th May 20137:00 amRNSFinal Results
12th Feb 201310:27 amRNS3rd Quarter Results
1st Nov 20129:12 amRNSAcquisition
30th Oct 201210:30 amRNSHalf Yearly Report
26th Jul 201210:33 amRNS1st Quarter Results
27th Apr 20126:28 pmRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.